Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.53 USD | +1.70% | -3.62% | -.--% |
05-14 | Kyverna Therapeutics Q1 Loss Narrows | MT |
05-14 | Kyverna Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
540M | - | - | - | - | - | |
54.63B | - | |||||
39.92B | ||||||
26.86B | ||||||
26.22B | ||||||
18.78B | - |